Literature DB >> 11299005

Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model.

C Mulenga1, J D Mhlanga, K Kristensson, B Robertson.   

Abstract

African trypanosomiasis, sleeping sickness in humans, is caused by the systemic infection of the host by the extracellular parasite, the African trypanosome. The pathogenetic mechanisms of the severe symptoms of central nervous system involvement are still not well understood. The present study examined the routes of haematogenous spread of Trypanosoma brucei brucei (Tbb) to the brain, in particular on the question whether parasites can cross the blood-brain barrier, as well as their effect on tight junction proteins. Rats were infected with Tbb and at various times post-infection, the location of the parasite in the central nervous system was examined in relation to the brain vascular endothelium, visualized with an anti-glucose transporter-1 antibody. The tight junction-specific proteins occludin and zonula occludens 1, and the possible activation of the endothelial cell adhesion molecules ICAM-1 and VCAM-1 were also studied. At 12 and 22 days post-infection, the large majority of parasites were confined within blood vessels. At this stage, however, some parasites were also clearly observed in the brain parenchyma. This was accompanied by an upregulation of ICAM-1/VCAM-1. At later stages, 42, 45 and 55 days post-infection, parasites could still be detected within or in association with blood vessels. In addition, the parasite was now frequently found in the brain parenchyma and the extravasation of parasites was more prominent in the white matter than the cerebral cortex. A marked penetration of parasites was seen in the septal nuclei. In spite of this, occludin and zonula occludens 1 staining of the vessels was preserved. The results indicate that the Tbb parasite is able to cross the blood-brain barrier in vivo, without a generalized loss of tight junction proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299005     DOI: 10.1046/j.0305-1846.2001.00306.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  33 in total

1.  MR imaging findings in African trypansomiasis.

Authors:  Danny S Gill; Deep S Chatha; Raquel del Carpio-O'Donovan
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

2.  Blood-brain barrier traversal by African trypanosomes requires calcium signaling induced by parasite cysteine protease.

Authors:  Olga V Nikolskaia; Ana Paula C de A Lima; Yuri V Kim; John D Lonsdale-Eccles; Toshihide Fukuma; Julio Scharfstein; Dennis J Grab
Journal:  J Clin Invest       Date:  2006-09-21       Impact factor: 14.808

3.  Using microdialysis to analyse the passage of monovalent nanobodies through the blood-brain barrier.

Authors:  G Caljon; V Caveliers; T Lahoutte; B Stijlemans; G H Ghassabeh; J Van Den Abbeele; I Smolders; P De Baetselier; Y Michotte; S Muyldermans; S Magez; R Clinckers
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

4.  Propulsion of African trypanosomes is driven by bihelical waves with alternating chirality separated by kinks.

Authors:  Jose A Rodríguez; Miguel A Lopez; Michelle C Thayer; Yunzhe Zhao; Michael Oberholzer; Donald D Chang; Neville K Kisalu; Manuel L Penichet; Gustavo Helguera; Robijn Bruinsma; Kent L Hill; Jianwei Miao
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-30       Impact factor: 11.205

5.  The distribution of nifurtimox across the healthy and trypanosome-infected murine blood-brain and blood-cerebrospinal fluid barriers.

Authors:  Sinthujah Jeganathan; Lisa Sanderson; Murat Dogruel; Jean Rodgers; Simon Croft; Sarah A Thomas
Journal:  J Pharmacol Exp Ther       Date:  2010-11-05       Impact factor: 4.030

6.  Minocycline impedes African trypanosome invasion of the brain in a murine model.

Authors:  Willias Masocha; Martin E Rottenberg; Krister Kristensson
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

7.  Distinct Toll-like receptor signals regulate cerebral parasite load and interferon α/β and tumor necrosis factor α-dependent T-cell infiltration in the brains of Trypanosoma brucei-infected mice.

Authors:  Daniel Ndem Amin; Suman K Vodnala; Willias Masocha; Bo Sun; Krister Kristensson; Martin E Rottenberg
Journal:  J Infect Dis       Date:  2011-11-23       Impact factor: 5.226

Review 8.  Motility and more: the flagellum of Trypanosoma brucei.

Authors:  Gerasimos Langousis; Kent L Hill
Journal:  Nat Rev Microbiol       Date:  2014-07       Impact factor: 60.633

9.  Mycophenolic Acid and Its Derivatives as Potential Chemotherapeutic Agents Targeting Inosine Monophosphate Dehydrogenase in Trypanosoma congolense.

Authors:  Keisuke Suganuma; Albertus Eka Yudistira Sarwono; Shinya Mitsuhashi; Marcin Jąkalski; Tadashi Okada; Molefe Nthatisi; Junya Yamagishi; Makoto Ubukata; Noboru Inoue
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

10.  Neurological trypanosomiasis in quinapyramine sulfate-treated horses--a breach of the blood-brain barrier?

Authors:  Muthusamy Ranjithkumar; Buddhi Chandrasekaran Saravanan; Suresh Chandra Yadav; Rajender Kumar; Rajendra Singh; Sahadeb Dey
Journal:  Trop Anim Health Prod       Date:  2013-11-06       Impact factor: 1.559

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.